Literature DB >> 4962249

Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth.

E Sanders, T H Maren.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 4962249

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  6 in total

Review 1.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

2.  Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae.

Authors:  Chad S Hewitt; Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Xufeng Cao; Devon P Amos; Molly S Youse; Katrina J Holly; Anil Kumar Marapaka; Weiwei An; Jatinder Kaur; Aaron D Krabill; Ahmed Elkashif; Yehia Elgammal; Amanda L Graboski; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty
Journal:  ACS Infect Dis       Date:  2021-03-25       Impact factor: 5.084

3.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

Review 4.  Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets.

Authors:  Daniel P Flaherty; Mohamed N Seleem; Claudiu T Supuran
Journal:  Future Med Chem       Date:  2021-08-12       Impact factor: 4.767

5.  Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae.

Authors:  Simone Giovannuzzi; Nader S Abutaleb; Chad S Hewitt; Fabrizio Carta; Alessio Nocentini; Mohamed N Seleem; Daniel P Flaherty; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae.

Authors:  Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Chad S Hewitt; Ahmed Elkashif; Bruce R Cooper; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.